1. Home
  2. ONCY vs CTM Comparison

ONCY vs CTM Comparison

Compare ONCY & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • CTM
  • Stock Information
  • Founded
  • ONCY 1998
  • CTM 2019
  • Country
  • ONCY Canada
  • CTM United States
  • Employees
  • ONCY N/A
  • CTM N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • CTM EDP Services
  • Sector
  • ONCY Health Care
  • CTM Technology
  • Exchange
  • ONCY Nasdaq
  • CTM Nasdaq
  • Market Cap
  • ONCY 49.2M
  • CTM 54.7M
  • IPO Year
  • ONCY 1999
  • CTM N/A
  • Fundamental
  • Price
  • ONCY $0.56
  • CTM $0.93
  • Analyst Decision
  • ONCY Strong Buy
  • CTM
  • Analyst Count
  • ONCY 3
  • CTM 0
  • Target Price
  • ONCY $4.33
  • CTM N/A
  • AVG Volume (30 Days)
  • ONCY 330.3K
  • CTM 2.1M
  • Earning Date
  • ONCY 05-08-2025
  • CTM 05-14-2025
  • Dividend Yield
  • ONCY N/A
  • CTM N/A
  • EPS Growth
  • ONCY N/A
  • CTM N/A
  • EPS
  • ONCY N/A
  • CTM N/A
  • Revenue
  • ONCY N/A
  • CTM $44,764,852.00
  • Revenue This Year
  • ONCY N/A
  • CTM N/A
  • Revenue Next Year
  • ONCY N/A
  • CTM N/A
  • P/E Ratio
  • ONCY N/A
  • CTM N/A
  • Revenue Growth
  • ONCY N/A
  • CTM N/A
  • 52 Week Low
  • ONCY $0.47
  • CTM $0.12
  • 52 Week High
  • ONCY $1.53
  • CTM $2.83
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 45.75
  • CTM 42.77
  • Support Level
  • ONCY $0.47
  • CTM $0.93
  • Resistance Level
  • ONCY $0.65
  • CTM $1.03
  • Average True Range (ATR)
  • ONCY 0.05
  • CTM 0.08
  • MACD
  • ONCY 0.01
  • CTM -0.01
  • Stochastic Oscillator
  • ONCY 50.00
  • CTM 40.94

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About CTM Castellum Inc.

Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.

Share on Social Networks: